drugset / Trial / NCT01783470
Effects of b3-Adrenergic Receptor Agonists on Brown Adipose Tissue
Phase 2
Completed
15 enrolled
Aaron Cypess
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collabNational Institutes of Health (NIH) · collab
NaSingle-groupOpen-labelBasic science
Summary
This study will test the hypothesis that human brown adipose tissue (BAT) can be activated using a β3-adrenergic receptor (AR) agonist. The efficacy of β3-AR agonist will be compared with cold exposure, which we have already shown can activate human BAT, as well as a placebo control.
Timeline
- Start
- 2013-02
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirabegron | Other / unclassified | 200 mg | Oral |